- Home
- REI vs PLX Comparison
REI vs PLX Comparison
Compare REI & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | REI | PLX |
|---|---|---|
| Founded | 2004 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.3M | 159.5M |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | REI | PLX |
|---|---|---|
| Price | $1.26 | $2.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 6.4M | 844.7K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $307,178,072.00 | $52,744,000.00 |
| Revenue This Year | N/A | $36.81 |
| Revenue Next Year | $10.17 | N/A |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $1.34 |
| 52 Week High | $2.00 | $3.19 |
Technical Indicators
Market Signals| Indicator | REI | PLX |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 56.78 |
| Support Level | $1.22 | $2.06 |
| Resistance Level | $1.64 | $2.42 |
| Average True Range (ATR) | 0.09 | 0.11 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 0.91 | 96.55 |
Price Performance
Historical ComparisonAbout REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.